F447-0653 Screening compound: 6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid

F447-0653 Screening compound: 6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid
F447-0653 Screening compound: 6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F447-0653
6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F447-0653

Molecular Formula

C24H28N4O4S (C24 H28 N4 O4 S)

Compound Name

6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid

IUPAC name

6-(3-methylbenzenesulfonamido)-2-(4-propylpiperazin-1-yl)quinoline-4-carboxylic acid

SMILES

CCCN(CC1)CCN1c1cc(C(O)=O)c(cc(cc2)NS(c3cc(C)ccc3)(=O)=O)c2n1

InChI

InChI=1S/C24H28N4O4S/c1-3-9-27-10-12-28(13-11-27)23-16-21(24(29)30)20-15-18(7-8-22(20)25-23)26-33(31,32)19-6-4-5-17(2)14-19/h4-8,14-16,26H,3,9-13H2,1-2H3,(H,29,30)

InChI Key

ZLEBSTUFBNUJFZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27129312

Chemical and Physical Properties

Saltdata

3HCl

Molecular Weight

468.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.820

Distribution Coefficient, logD

4.820

Water Solubility, LogSw

-4.31

Polar Surface Area

84.333

Acid Dissociation Constant (pKa)

5.05

Base Dissociation Constant (pKb)

8.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

F447-0653 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SH2 Library (10483 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Endocrine
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with F447-0653 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F447-0653?
Check Price and Availability of F447-0653, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F447-0653 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F447-0653
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F447-0653
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F447-0653 available by request